Podcasts about epilepsy treatment

How do you turn massive clinical imaging data into insights that change lives? What does it take to move from a psychology undergrad to a pioneering role in pediatric brain research? And how can coding, connectomics, and curiosity shape a meaningful clinical career in neuroscience? In this inspiring episode of Neurocareers: Doing the Impossible!, we sit down with Dr. Puck Reeders, Senior Neuroscience Research Scientist at the Brain Institute at Nicklaus Children's Hospital. From her early days in Curacao to building novel neuroimaging pipelines in one of the nation's oldest pediatric epilepsy programs, Dr. Reeders shares her unique career path—and how she helps decode complex brain networks to improve surgical outcomes for children with intractable epilepsy. We explore: How connectomics and diffusion imaging guide surgical planning Her innovative research on white matter networks and neuromodulation responses The steep but rewarding path from zero coding skills to advanced tractography Tips for transitioning from psychology to clinical neuroscience Career advice for anyone eager to enter research-focused medical settings Whether you're a student exploring future careers, a neuroscientist curious about clinical impact, or just fascinated by how science meets medicine—you'll walk away informed and inspired. Chapters: 00:00:00 - Insights from a Neuroscience Research Scientist 00:03:00 - Functional Mapping Techniques for Epilepsy 00:08:43 - Transitioning from Medical School to Psychology 00:13:10 - Research Gaps in Epilepsy 00:17:10 - Understanding Connectomics in Epilepsy Treatment 00:21:53 - Combining Imaging Techniques in Research 00:24:50 - Coding Challenges in Research 00:27:12 - Coding Journey in Neuroscience 00:28:51 - Learning to Code: A Personal Journey 00:32:39 - The Importance of Networking 00:34:30 - Art's Role in Science Communication 00:37:38 - Landing a Job Through Networking 00:41:22 - Research Opportunities in Connectomics 00:46:49 - Exploring Diverse Career Opportunities 00:51:38 - Job Search Tips and Strategies 00:54:39 - Tips for Job Applications and Interviews 00:59:46 - From Medicine to Neuroscience Research 01:02:06 - Clinical Research and Pediatric Epilepsy About the Podcast Guest: Dr. Puck Reeders is a Senior Neuroscience Research Scientist at the Brain Institute at Nicklaus Children's Hospital in Miami, Florida https://www.nicklauschildrens.org/home Her work focuses on investigating aberrant brain networks in children with intractable epilepsy, applying advanced neuroimaging techniques to improve clinical outcomes in pediatric neurology. Originally from the Netherlands and raised on the island of Curaçao, Dr. Reeders brings a global perspective to her research. She holds a Bachelor of Science in Psychology and Chemistry from the University of Miami, and a PhD in Cognitive Neuroscience from Florida International University, where she also completed her postdoctoral training in the Allen Neurocircuitry and Cognition Lab. Dr. Reeders has over nine years of experience working with functional MRI (fMRI) and diffusion-weighted imaging (DWI) in both adults and children. Her current research explores the structural connectomics of pediatric epilepsy, the development of clinical imaging pipelines to detect white matter abnormalities, cortical dysplasias, and automated SPECT subtractions—bringing together cutting-edge science with translational clinical impact. Her expertise spans: Neuroimaging and clinical pipeline development Data analysis and scientific coding Translational neuroscience and surgical planning support Research project design and academic mentoring Outside of the lab, Dr. Reeders shares insights into neuroscience careers and research life on her educational Instagram: @Drpucky You can also connect with her professionally on LinkedIn:  https://www.linkedin.com/in/puckreeders/  About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

Urgent Action Needed to Address Epilepsy Treatment Gap by Radio Islam

Prof Lawrence Tucker, Past-President of the Neurological Association of South AfricaSee omnystudio.com/listener for privacy information.

Madeline Oudin, Ph.D., is a scientist and mother on a groundbreaking mission to help her daughter, Margot, who has two de novo mutations in the SCN8A gene, which causes epilepsy. Margot's condition causes frequent seizures and developmental challenges. Determined to make a difference, Madeleine and her team are pioneering a cutting-edge genetic therapy that could one day transform treatment for Margot and others like her. In this heartfelt talk, Madeleine shares how her scientific expertise and personal journey intersect, revealing the highs and lows of developing life-changing treatments. From innovative approaches using Antisense Oligonucleotides (ASOs) to the unexpected success of a ketogenic diet, this story is about resilience, hope, and the power of community. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 40210]

Madeline Oudin, Ph.D., is a scientist and mother on a groundbreaking mission to help her daughter, Margot, who has two de novo mutations in the SCN8A gene, which causes epilepsy. Margot's condition causes frequent seizures and developmental challenges. Determined to make a difference, Madeleine and her team are pioneering a cutting-edge genetic therapy that could one day transform treatment for Margot and others like her. In this heartfelt talk, Madeleine shares how her scientific expertise and personal journey intersect, revealing the highs and lows of developing life-changing treatments. From innovative approaches using Antisense Oligonucleotides (ASOs) to the unexpected success of a ketogenic diet, this story is about resilience, hope, and the power of community. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 40210]

Madeline Oudin, Ph.D., is a scientist and mother on a groundbreaking mission to help her daughter, Margot, who has two de novo mutations in the SCN8A gene, which causes epilepsy. Margot's condition causes frequent seizures and developmental challenges. Determined to make a difference, Madeleine and her team are pioneering a cutting-edge genetic therapy that could one day transform treatment for Margot and others like her. In this heartfelt talk, Madeleine shares how her scientific expertise and personal journey intersect, revealing the highs and lows of developing life-changing treatments. From innovative approaches using Antisense Oligonucleotides (ASOs) to the unexpected success of a ketogenic diet, this story is about resilience, hope, and the power of community. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 40210]

Madeline Oudin, Ph.D., is a scientist and mother on a groundbreaking mission to help her daughter, Margot, who has two de novo mutations in the SCN8A gene, which causes epilepsy. Margot's condition causes frequent seizures and developmental challenges. Determined to make a difference, Madeleine and her team are pioneering a cutting-edge genetic therapy that could one day transform treatment for Margot and others like her. In this heartfelt talk, Madeleine shares how her scientific expertise and personal journey intersect, revealing the highs and lows of developing life-changing treatments. From innovative approaches using Antisense Oligonucleotides (ASOs) to the unexpected success of a ketogenic diet, this story is about resilience, hope, and the power of community. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 40210]

Madeline Oudin, Ph.D., is a scientist and mother on a groundbreaking mission to help her daughter, Margot, who has two de novo mutations in the SCN8A gene, which causes epilepsy. Margot's condition causes frequent seizures and developmental challenges. Determined to make a difference, Madeleine and her team are pioneering a cutting-edge genetic therapy that could one day transform treatment for Margot and others like her. In this heartfelt talk, Madeleine shares how her scientific expertise and personal journey intersect, revealing the highs and lows of developing life-changing treatments. From innovative approaches using Antisense Oligonucleotides (ASOs) to the unexpected success of a ketogenic diet, this story is about resilience, hope, and the power of community. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 40210]

Madeline Oudin, Ph.D., is a scientist and mother on a groundbreaking mission to help her daughter, Margot, who has two de novo mutations in the SCN8A gene, which causes epilepsy. Margot's condition causes frequent seizures and developmental challenges. Determined to make a difference, Madeleine and her team are pioneering a cutting-edge genetic therapy that could one day transform treatment for Margot and others like her. In this heartfelt talk, Madeleine shares how her scientific expertise and personal journey intersect, revealing the highs and lows of developing life-changing treatments. From innovative approaches using Antisense Oligonucleotides (ASOs) to the unexpected success of a ketogenic diet, this story is about resilience, hope, and the power of community. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 40210]

Madeline Oudin, Ph.D., is a scientist and mother on a groundbreaking mission to help her daughter, Margot, who has two de novo mutations in the SCN8A gene, which causes epilepsy. Margot's condition causes frequent seizures and developmental challenges. Determined to make a difference, Madeleine and her team are pioneering a cutting-edge genetic therapy that could one day transform treatment for Margot and others like her. In this heartfelt talk, Madeleine shares how her scientific expertise and personal journey intersect, revealing the highs and lows of developing life-changing treatments. From innovative approaches using Antisense Oligonucleotides (ASOs) to the unexpected success of a ketogenic diet, this story is about resilience, hope, and the power of community. Series: "Autism Tree Project Annual Neuroscience Conference" [Health and Medicine] [Science] [Show ID: 40210]

Have you heard of temporal interference (TI) electrical stimulation, a revolutionary concept of non-invasive deep brain stimulation (DBS)? Curious about what it takes to develop cutting-edge neuromodulation techniques while pursuing a scientific career across two continents? Welcome to the Women in Neurotech series on the Neurocareers: Doing the Impossible! podcast!

Join Startuprad.io, the authority on the DACH region's vibrant startup ecosystem, for an exclusive interview with Karl Stoklosa, CEO of PRECISIS, a healthcare startup revolutionizing epilepsy treatment through cutting-edge technology. In this episode, we explore how PRECISIS is leveraging its groundbreaking EASI System—the world's first minimally invasive brain pacemaker—to improve the lives of epilepsy patients worldwide. What You'll Learn in This Episode:Karl Stoklosa's Leadership Journey: From an Executive MBA at the University of Chicago Booth School to leading a disruptive healthcare startup, Karl shares insights into his 20+ years of experience in the medical device industry, spanning roles in neuromodulation, cardiac rhythm management, and global healthcare marketing. The Global Epilepsy Challenge: With 50 million epilepsy patients worldwide and 30% classified as drug-resistant, the need for innovative solutions is critical. Discover how PRECISIS is addressing this gap with the EASI System, providing safer, more effective alternatives to invasive surgeries and medications. The EASI System's Impact: Learn about this state-of-the-art neuromodulation device, its minimally invasive design, and its ability to reduce seizures by 50% or more for most patients. With features like manual stimulation for oncoming seizures and MRI compatibility, the EASI System sets a new standard in epilepsy care. PRECISIS' European Success: PRECISIS has achieved market approval in key European countries, including Germany, Austria, Switzerland, the UK, and Portugal, and is scaling its commercial operations. Expansion into the U.S. Market: With FDA breakthrough designation, PRECISIS is preparing for clinical trials in the U.S., showcasing its ambition to become a global leader in medical device innovation. Call to Action:Love what you hear? Share this episode, leave us a review, and subscribe to Startuprad.io to stay updated on the latest from the startup ecosystem in Germany, Austria, Switzerland, and beyond! Explore:Original Blog Post: https://www.startuprad.io/blog/innovating-epilepsy-treatment-with-precisis-a-healthcare-startup-revolutionizing-technology Work With Us: https://www.startuprad.io/become-a-partner Subscribe: https://linktr.ee/startupradio Give Feedback: https://forms.gle/SrcGUpycu26fvMFE9 Follow the Editor-in-Chief: Jörn Menninger on LinkedIn Special Offer: Startuprad.io listeners can create two free SEO-optimized blog posts per month with ModernIQs.com. Sign up now to claim this exclusive deal! Interested in Working with us? Have a look here: https://www.passionfroot.me/startupradio

On this episode, we discuss the various antiseizure medications used to manage a patient with Epilepsy. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! We want to give a big thanks to our sponsor, High-Powered Medicine. HPM is a book/website database of summaries for over 150 landmark clinical trials. You can get a copy of HPM, written by Dr. Alex Poppen, PharmD, at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:  www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx  This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

Combining data, guidelines, and experience to select appropriate treatments for individuals with focal epilepsy. Credit available for this activity expires: 5/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000865?ecd=bdc_podcast_libsyn_mscpedu

In this episode of the Ketones and Coffee Podcast, host Lawrence delves into the impactful story of Jillian Zolas, a health policy promotion and education consultant who reclaimed her health and well-being through the ketogenic diet. Jillian shares her personal journey, from struggling with left temporal lobe epilepsy and the detrimental side effects of medications to discovering the life-changing benefits of a therapeutic ketogenic diet. With eight years of being seizure-free, Jillian's story highlights the profound therapeutic potential of keto, not just for epilepsy but for overall health improvement. She discusses the importance of nutritional quality, the pitfalls of 'keto' branded products, and offers practical advice for individuals considering a ketogenic lifestyle for therapeutic purposes. Jillian's narrative is a testament to the power of dietary intervention and the importance of community, support, and education in navigating health challenges.00:00 Welcome to the Ketones and Coffee Podcast!00:27 Introducing Jillian Zolas: A Ketogenic Success Story02:21 Jillian's Journey: From Seizures to Keto Triumph09:29 The Therapeutic Power of Keto: A Deep Dive14:53 Navigating Keto: Challenges, Support, and Lifestyle Changes20:00 The Importance of Support and Precision in Keto Success23:36 Keto Misconceptions and the Path to True Ketosis27:59 The Importance of Real Food in Your Diet29:10 Navigating Keto: Personal Experiences and Adjustments30:27 Addressing Health Conditions Beyond Diet31:14 The Journey of Weight Loss and Managing Lipedema31:36 Adapting Keto for Menopause and Personal Health Goals34:06 The Role of Medical Supervision in Medication and Diet Changes36:18 Engaging with Your Doctor on a Keto Diet Plan39:46 The Power of Coaching and Mental Shifts in Keto Success41:39 Understanding and Utilizing Ketones for Health46:54 The Sweetness Dilemma: Adjusting to Healthier Choices53:08 Closing Thoughts and Where to Find More Information~~~~~~Estrella by Audiorezout is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International License.~~~~~~ Save yourself that trip to the market — Instacart delivers groceries in as fast as 1 hour! They connect you with Personal Shoppers in your area to shop and deliver groceries from your favorite stores.Instacart - Groceries delivered in as little as 1 hour. Free delivery on your first order over $35. Go to ketocoachlorenz.com and use the contact form to get your Free Consultation!Support the show

In this episode of the Ketones and Coffee Podcast, host Lawrence delves into the impactful story of Jillian Zolas, a health policy promotion and education consultant who reclaimed her health and well-being through the ketogenic diet. Jillian shares her personal journey, from struggling with left temporal lobe epilepsy and the detrimental side effects of medications to discovering the life-changing benefits of a therapeutic ketogenic diet. With eight years of being seizure-free, Jillian's story highlights the profound therapeutic potential of keto, not just for epilepsy but for overall health improvement. She discusses the importance of nutritional quality, the pitfalls of 'keto' branded products, and offers practical advice for individuals considering a ketogenic lifestyle for therapeutic purposes. Jillian's narrative is a testament to the power of dietary intervention and the importance of community, support, and education in navigating health challenges.00:00 Welcome to the Ketones and Coffee Podcast!00:27 Introducing Jillian Zolas: A Ketogenic Success Story02:21 Jillian's Journey: From Seizures to Keto Triumph09:29 The Therapeutic Power of Keto: A Deep Dive14:53 Navigating Keto: Challenges, Support, and Lifestyle Changes20:00 The Importance of Support and Precision in Keto Success23:36 Keto Misconceptions and the Path to True Ketosis27:59 The Importance of Real Food in Your Diet29:10 Navigating Keto: Personal Experiences and Adjustments30:27 Addressing Health Conditions Beyond Diet31:14 The Journey of Weight Loss and Managing Lipedema31:36 Adapting Keto for Menopause and Personal Health Goals34:06 The Role of Medical Supervision in Medication and Diet Changes36:18 Engaging with Your Doctor on a Keto Diet Plan39:46 The Power of Coaching and Mental Shifts in Keto Success41:39 Understanding and Utilizing Ketones for Health46:54 The Sweetness Dilemma: Adjusting to Healthier Choices53:08 Closing Thoughts and Where to Find More Information~~~~~~Estrella by Audiorezout is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International License.~~~~~~ Save yourself that trip to the market — Instacart delivers groceries in as fast as 1 hour! They connect you with Personal Shoppers in your area to shop and deliver groceries from your favorite stores.Instacart - Groceries delivered in as little as 1 hour. Free delivery on your first order over $35. Go to ketocoachlorenz.com and use the contact form to get your Free Consultation!Support the show

In this episode, host Dan Klein learns about Pretola Global Health and Consulting Limited and how they advocate for a better future for people living with epilepsy, learning disability and autism around the world. Earlier this year, the TSC Alliance partnered with Pretola on the 4th edition of the Epilepsy Assessment and Management Course, an … Continue reading Episode 47: Closing the Epilepsy Treatment Gap Worldwide →

This week on Seizing Life® Clare Phelps shares the difficult diagnosis and frustrating treatment journey of her young daughter Sophie, whose epilepsy has so far been treatment resistant. The post Pursuing Effective Epilepsy Treatment and Running for Research appeared first on CURE Epilepsy.

This week on Seizing Life® Clare Phelps shares the difficult diagnosis and frustrating treatment journey of her young daughter Sophie, whose epilepsy has so far been treatment resistant. The post Pursuing Effective Epilepsy Treatment and Running for Research appeared first on CURE Epilepsy.

Dr. Dario Englot is an Associate Professor of Neurological Surgery, Neurology, Radiology & Radiological Sciences and the Surgical Director of Epilepsy at Vanderbilt University Medical Center. Dr. Englot's clinical interests include epilepsy, neuromodulation, movement disorders, pain disorders, and general neurosurgery. He also leads an active research laboratory studying brain networks in neurological disorders using neuroimaging and electrophysiology, with a particular focus in epilepsy. Dr. Englot completed his residency at University of California and his fellowship in functional neurosurgery and epilepsy at Vanderbilt. Today we are going to be speaking with Dr. Englot about using the human brain connectome to guide epilepsy treatment.

In this podcast episode, epileptologists Aatif Husain, MD, and John Stern, MD, have a conversation about rescue therapies and how they fit into the spectrum of epilepsy management. Their discussion begins with sharing what they consider the utility of rescue therapies to be in the overall spectrum of epilepsy. As the conversation goes on, they address the role of rescue therapies in more specific patient populations, such as the newly diagnosed patient, a patient experiencing seizure clusters, and patients who may be experiencing either very few or relatively many breakthrough seizure events. In all scenarios, the experts relate the use of rescue therapies as “insurance”—hoping that the agents don't have to be used, but having them available as coverage in the worst-case scenario. The podcast goes on to discuss rescue therapies in terms of available routes and mechanisms of action and practical strategies for talking to patients about these agents. Rounding out the episode, Drs Husain and Stern express their hopes for future developments in epilepsy management.Presenters:Aatif Husain, MDProfessorDivision of Epilepsy, Sleep and Clinical NeurophysiologyDepartment of NeurologyDuke University Medical CenterDurham, North CarolinaJohn Stern, MDProfessorNeurologyGeffen School of Medicine, UCLADirectorEpilepsy Clinical ProgramUCLA Department of NeurologyLos Angeles, CaliforniaThis content is based on a CE/CME program supported by an independent educational grant from Neurelis, Inc.For additional activities in this program, visit https://bit.ly/3GiLlu4.

Avicanna Vice President of Medical Affairs Dr. Karolina Urban joins Natalie Stoberman from the Proactive studio to share details behind the company's research on cannabinoid treatment for epilepsy. Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments. #proactiveinvestors #avicanna #TSX #AVCN #OTCQX #AVCNF #biopharmaceuticals #cannabis #cannabinoids #epilepsytreatment

Huberman Lab Podcast Notes Key Takeaways Nutrition and mental health interact intimately and even causally in some casesProcessed foods rich in fat, carbohydrates, and sugar are the worst for metabolic health and mental healthInsulin resistance is impaired in people with chronic mental disordersA ketogenic diet has shown beneficial effects in the treatment of chronic depression, PTSD, Alzheimer's, alcohol use disorder, bipolar disorder, schizophrenia, epilepsyThe beauty of the ketogenic diet for intervention is you can measure with objective biomarkers“Once you understand the science of mitochondria, you can actually connect all the dots of the mental health puzzle.” – Dr. Chris PalmerCalorie restriction, ketogenic diet, and carbohydrate restriction are inducing metabolic changes in the brain and body that can be beneficial to brain health – it's not just about villainizing sugar or carbohydrates aloneJust like medication, dose the diet: for some people, symptoms can be reduced without fully being on a ketogenic diet; just cutting highly processed foods rich in carbohydrates, fat, and sugar is sufficientThe obesity epidemic is really a mystery though we want to believe it's diet; it's not as simple as energy balance or food – we had junk food and highly processed diets in the 70s – it's likely mitochondrial health deficits Sleep disruption, stress, trauma, drug and alcohol use, tobacco, and THC impair mitochondria and mitochondrial dysfunction“I see obesity as a symptom of metabolic derangement in the body or brain…and if we're really going to get anywhere we need to identify what is causing metabolic derangement.” – Dr. Chris PalmerExogenous ketones or supplementing with ketones while on a standard diet isn't enough The ketogenic diet isn't just about ketones, people on the diet are also lowering glucose levels, improving insulin signaling, ramping up mitochondrial biogenesis (particularly in the liver), gut microbiome changes, hormones are repaired, etc.  Read the full notes @ podcastnotes.orgMy guest this episode is Chris Palmer, M.D., a board-certified psychiatrist and assistant professor of psychiatry at Harvard Medical School. He explains the important connection between nutrition, metabolism and mental health and his pioneering work using the ketogenic diet to successfully treat patients with various mental illnesses, including depression and schizophrenia. Dr. Palmer explains how the ketogenic diet is an evidenced-based treatment for epilepsy, mimics the fasted state and can offset the cognitive decline in Alzheimer's. He describes the key roles of mitochondria in mental health, how certain conditions likely arise from mitochondrial dysfunction, and how low-carbohydrate diets increase mitochondrial turnover to improve mental health. He also explains how low-carbohydrate diets positively impact the gut microbiome and weight loss, important risk factors for mitochondrial health such as marijuana and alcohol, and the best way to increase circulating ketones depending on individual needs. We also cover how a ketogenic diet impacts mood, sleep, and fertility. Dr. Palmer's work stands as a revolutionary approach to mental health and disease that, given the prevalence of mental health challenges, should be of interest to people of all backgrounds and ages. Thank you to our sponsors AG1 (Athletic Greens): https://athleticgreens.com/huberman Thesis: https://takethesis.com/huberman Eight Sleep: https://www.eightsleep.com/huberman ROKA: https://www.roka.com/huberman InsideTracker: https://www.insidetracker.com/huberman Supplements from Momentous https://www.livemomentous.com/huberman For the full show notes, visit hubermanlab.com Timestamps (00:00:00) Dr. Chris Palmer, Mental Health & Metabolic Disorders (00:03:25) Thesis, Eight Sleep, ROKA (00:07:18) Nutrition & Mental Health (00:20:43) Low-Carb Diets & Anti-Depression, Fasting, Ketosis (00:27:52) Schizophrenia, Depression & Ketogenic Diet (00:34:32) AG1 (Athletic Greens) (00:35:38) Psychiatric Mediations, Diet Adherence (00:42:35) Highly Processed Foods, Ketones & Mental Health Benefits (00:46:51) Ketogenic Diet & Epilepsy Treatment (00:56:10) Ketogenic Diet & Mitochondria Health (00:57:05) Nutrition & Benefits for Neurologic/Psychiatric Disorders (01:05:44) Mitochondrial Function & Mental Health (01:15:12) InsideTracker (01:16:23) Mitophagy, Mitochondrial Dysfunction, Aging & Diet (01:25:09) Neurons, Mitochondria & Blood Glucose (01:31:54) Obesity, Ketogenic Diet & Mitochondria (01:40:00) Mitochondrial Function: Inheritance, Risk Factors, Marijuana  (01:46:34) Alcohol & Ketogenic Diet (01:55:21) Brain Imaging, Alzheimer's Disease & Ketones (02:01:05) Exogenous (Liquid) Ketones vs. Ketogenic Diet (02:06:27) Neuronal Damage, Ketones & Glucose  (02:10:16) Alzheimer's Disease, Age-Related Cognitive Decline & Ketogenic Diet (02:23:45) Ketogenic Diet & Weight Loss (02:35:47) Ketogenic Diet & Fasting, Hypomania, Sleep (02:46:37) Low Carbohydrate Diets, Menstrual Cycles, Fertility (02:52:23) Obesity Epidemic, Semaglutide & GLP-1 Medications  (03:01:01) Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous Supplements, Neural Network Newsletter, Social Media Disclaimer Title Card Photo Credit: Mike Blabac

Huberman Lab Podcast Notes Key Takeaways Nutrition and mental health interact intimately and even causally in some casesProcessed foods rich in fat, carbohydrates, and sugar are the worst for metabolic health and mental healthInsulin resistance is impaired in people with chronic mental disordersA ketogenic diet has shown beneficial effects in the treatment of chronic depression, PTSD, Alzheimer's, alcohol use disorder, bipolar disorder, schizophrenia, epilepsyThe beauty of the ketogenic diet for intervention is you can measure with objective biomarkers“Once you understand the science of mitochondria, you can actually connect all the dots of the mental health puzzle.” – Dr. Chris PalmerCalorie restriction, ketogenic diet, and carbohydrate restriction are inducing metabolic changes in the brain and body that can be beneficial to brain health – it's not just about villainizing sugar or carbohydrates aloneJust like medication, dose the diet: for some people, symptoms can be reduced without fully being on a ketogenic diet; just cutting highly processed foods rich in carbohydrates, fat, and sugar is sufficientThe obesity epidemic is really a mystery though we want to believe it's diet; it's not as simple as energy balance or food – we had junk food and highly processed diets in the 70s – it's likely mitochondrial health deficits Sleep disruption, stress, trauma, drug and alcohol use, tobacco, and THC impair mitochondria and mitochondrial dysfunction“I see obesity as a symptom of metabolic derangement in the body or brain…and if we're really going to get anywhere we need to identify what is causing metabolic derangement.” – Dr. Chris PalmerExogenous ketones or supplementing with ketones while on a standard diet isn't enough The ketogenic diet isn't just about ketones, people on the diet are also lowering glucose levels, improving insulin signaling, ramping up mitochondrial biogenesis (particularly in the liver), gut microbiome changes, hormones are repaired, etc.  Read the full notes @ podcastnotes.orgMy guest this episode is Chris Palmer, M.D., a board-certified psychiatrist and assistant professor of psychiatry at Harvard Medical School. He explains the important connection between nutrition, metabolism and mental health and his pioneering work using the ketogenic diet to successfully treat patients with various mental illnesses, including depression and schizophrenia. Dr. Palmer explains how the ketogenic diet is an evidenced-based treatment for epilepsy, mimics the fasted state and can offset the cognitive decline in Alzheimer's. He describes the key roles of mitochondria in mental health, how certain conditions likely arise from mitochondrial dysfunction, and how low-carbohydrate diets increase mitochondrial turnover to improve mental health. He also explains how low-carbohydrate diets positively impact the gut microbiome and weight loss, important risk factors for mitochondrial health such as marijuana and alcohol, and the best way to increase circulating ketones depending on individual needs. We also cover how a ketogenic diet impacts mood, sleep, and fertility. Dr. Palmer's work stands as a revolutionary approach to mental health and disease that, given the prevalence of mental health challenges, should be of interest to people of all backgrounds and ages. Thank you to our sponsors AG1 (Athletic Greens): https://athleticgreens.com/huberman Thesis: https://takethesis.com/huberman Eight Sleep: https://www.eightsleep.com/huberman ROKA: https://www.roka.com/huberman InsideTracker: https://www.insidetracker.com/huberman Supplements from Momentous https://www.livemomentous.com/huberman For the full show notes, visit hubermanlab.com Timestamps (00:00:00) Dr. Chris Palmer, Mental Health & Metabolic Disorders (00:03:25) Thesis, Eight Sleep, ROKA (00:07:18) Nutrition & Mental Health (00:20:43) Low-Carb Diets & Anti-Depression, Fasting, Ketosis (00:27:52) Schizophrenia, Depression & Ketogenic Diet (00:34:32) AG1 (Athletic Greens) (00:35:38) Psychiatric Mediations, Diet Adherence (00:42:35) Highly Processed Foods, Ketones & Mental Health Benefits (00:46:51) Ketogenic Diet & Epilepsy Treatment (00:56:10) Ketogenic Diet & Mitochondria Health (00:57:05) Nutrition & Benefits for Neurologic/Psychiatric Disorders (01:05:44) Mitochondrial Function & Mental Health (01:15:12) InsideTracker (01:16:23) Mitophagy, Mitochondrial Dysfunction, Aging & Diet (01:25:09) Neurons, Mitochondria & Blood Glucose (01:31:54) Obesity, Ketogenic Diet & Mitochondria (01:40:00) Mitochondrial Function: Inheritance, Risk Factors, Marijuana  (01:46:34) Alcohol & Ketogenic Diet (01:55:21) Brain Imaging, Alzheimer's Disease & Ketones (02:01:05) Exogenous (Liquid) Ketones vs. Ketogenic Diet (02:06:27) Neuronal Damage, Ketones & Glucose  (02:10:16) Alzheimer's Disease, Age-Related Cognitive Decline & Ketogenic Diet (02:23:45) Ketogenic Diet & Weight Loss (02:35:47) Ketogenic Diet & Fasting, Hypomania, Sleep (02:46:37) Low Carbohydrate Diets, Menstrual Cycles, Fertility (02:52:23) Obesity Epidemic, Semaglutide & GLP-1 Medications  (03:01:01) Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous Supplements, Neural Network Newsletter, Social Media Disclaimer Title Card Photo Credit: Mike Blabac

Did you know there is a direct correlation to cholesterol and gall stones? Painful gall stones and even gall bladder removal can be prevented, mostly from diet. Listen as Dr. Scott Bloemendal, General Surgeon at Texas Health Harris Methodist Hospital Fort Worth, discusses how to take better care of this important, and often overlooked, organ in our body. November is Epilepsy Awareness Month and we are joined by Dr. Scott Perry, Head of Neurosciences at Cook Children's to discuss this disease that affects 1 in 26 Americans, on average.

My guest this episode is Chris Palmer, M.D., a board-certified psychiatrist and assistant professor of psychiatry at Harvard Medical School. He explains the important connection between nutrition, metabolism and mental health and his pioneering work using the ketogenic diet to successfully treat patients with various mental illnesses, including depression and schizophrenia. Dr. Palmer explains how the ketogenic diet is an evidenced-based treatment for epilepsy, mimics the fasted state and can offset the cognitive decline in Alzheimer's. He describes the key roles of mitochondria in mental health, how certain conditions likely arise from mitochondrial dysfunction, and how low-carbohydrate diets increase mitochondrial turnover to improve mental health. He also explains how low-carbohydrate diets positively impact the gut microbiome and weight loss, important risk factors for mitochondrial health such as marijuana and alcohol, and the best way to increase circulating ketones depending on individual needs. We also cover how a ketogenic diet impacts mood, sleep, and fertility. Dr. Palmer's work stands as a revolutionary approach to mental health and disease that, given the prevalence of mental health challenges, should be of interest to people of all backgrounds and ages. Thank you to our sponsors AG1 (Athletic Greens): https://athleticgreens.com/huberman Thesis: https://takethesis.com/huberman Eight Sleep: https://www.eightsleep.com/huberman ROKA: https://www.roka.com/huberman InsideTracker: https://www.insidetracker.com/huberman Supplements from Momentous https://www.livemomentous.com/huberman For the full show notes, visit hubermanlab.com Timestamps (00:00:00) Dr. Chris Palmer, Mental Health & Metabolic Disorders (00:03:25) Thesis, Eight Sleep, ROKA (00:07:18) Nutrition & Mental Health (00:20:43) Low-Carb Diets & Anti-Depression, Fasting, Ketosis (00:27:52) Schizophrenia, Depression & Ketogenic Diet (00:34:32) AG1 (Athletic Greens) (00:35:38) Psychiatric Mediations, Diet Adherence (00:42:35) Highly Processed Foods, Ketones & Mental Health Benefits (00:46:51) Ketogenic Diet & Epilepsy Treatment (00:56:10) Ketogenic Diet & Mitochondria Health (00:57:05) Nutrition & Benefits for Neurologic/Psychiatric Disorders (01:05:44) Mitochondrial Function & Mental Health (01:15:12) InsideTracker (01:16:23) Mitophagy, Mitochondrial Dysfunction, Aging & Diet (01:25:09) Neurons, Mitochondria & Blood Glucose (01:31:54) Obesity, Ketogenic Diet & Mitochondria (01:40:00) Mitochondrial Function: Inheritance, Risk Factors, Marijuana  (01:46:34) Alcohol & Ketogenic Diet (01:55:21) Brain Imaging, Alzheimer's Disease & Ketones (02:01:05) Exogenous (Liquid) Ketones vs. Ketogenic Diet (02:06:27) Neuronal Damage, Ketones & Glucose  (02:10:16) Alzheimer's Disease, Age-Related Cognitive Decline & Ketogenic Diet (02:23:45) Ketogenic Diet & Weight Loss (02:35:47) Ketogenic Diet & Fasting, Hypomania, Sleep (02:46:37) Low Carbohydrate Diets, Menstrual Cycles, Fertility (02:52:23) Obesity Epidemic, Semaglutide & GLP-1 Medications  (03:01:01) Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous Supplements, Neural Network Newsletter, Social Media Disclaimer Title Card Photo Credit: Mike Blabac

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Christopher Elder, MD, clinical assistant professor of neurology, Comprehensive Epilepsy Center, NYU Langone Health. He joined the show to talk about the latest updates in the care of patients with epilepsy, the clinical therapeutic pipeline developments on the horizon, and the need to continue stressing conversations around sudden unexpected death in epilepsy (SUDEP). Episode Breakdown: 1:15 – The rise of neurostimulation in epilepsy care 4:00 – Increasing implantation of minimally invasive options 5:15 – Patient reception to nontherapeutic approaches 7:45 – The impact of cenobamate (Xcopri; SK Life Science) on the paradigm 10:35 – Managing refractory epilepsy 12:00 – Upcoming options for those with generalized epilepsy 13:50 – Neurology News Minute 18:30 – Path forward for gene and cell therapies in epilepsy 21:00 – The need to improve early recognition of epilepsy 25:20 – Standardizing questionnaires and information for epilepsy 27:00 – The need to continue discussing SUDEP This episode is brought to you by the Medical World News streaming service. Check out new content and shows every day, only at medicalworldnews.com The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Midazolam Autoinjector for Status Epilepticus Sirolimus Topical Gel Available for Facial Angiofibroma Associated With Tuberous Sclerosis Complex FDA Lifts Hold on Phase 2 Trial of SRP-5051 in DMD Amenable to Exon 51 Skipping Philips Respironics Recalls Masks for BPAP and CPAP Machines After Safety Concerns FDA Advisory Committee Votes to Recommend AMX0035 for Treatment of ALS Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

In this episode of Med Tech Talks, Robert Klupacs CEO of the Bionics Institute, a world leader in the development of medical devices, talks to leading neurologist Professor Mark Cook AO on his innovations to help predict and monitor seizures in patients with epilepsy. Professor Cook has been profoundly inspired to undertake a career in neurology through witnessing his father's struggles with epilepsy.Through his internationally renowned research and the foundations of two MedTech companies, Seer Medical and Epi-Minder, Professor Cook has made a tremendous impact in the treatment of epilepsy. In this episode you will hear about:Professor Cook's research and innovations to better treat epilepsyThe founding and mission of Seer Medical and Epi-MinderMark's thoughts on building Australia from innovationMore information:Read Mark Cook's biography : Professor Mark CookTake a look at the Epi-Minder website: Epi-MinderVisit the Seer Medical website: Seer Medical To find out more about commercialisation of research through medical device spin-off companies at the Bionics Institute, go to: Our Impact  Updated version 05/08/22

Read Dr. Ricci's paper here: https://doi.org/10.1016/j.clinph.2021.08.024 If you would like to get in touch with the show our email is: clinicalneuroasktheexperts@gmail.com Links to the Internal Federation of Clinical Neurophysiology Social MediaTwitter - https://twitter.com/ClinicalNeuroph/Facebook - https://www.facebook.com/ClinicalNeurophysiology/Instagram - https://www.instagram.com/clinicalneuroph/Linkedin -https://www.linkedin.com/in/ClinicalNeurophysiology/detail/recent-activity/

Interview with Upstate neurologist Shahram Izadyar, MD

There is no cure for epilepsy, but there are many different epilepsy treatment options that may help control seizures. This includes anticonvulsant medications, brain surgery and electrical stimulation from brain devices. I'll review each one of these treatments!  Epilepsy TreatmentSeize Life's Moments WebsiteInsta: @seizelifesmoments 

A New Zealand dietician has helped develop an app set to revolutionise the way some children are treated for epilepsy. It helps dieticians and parents using a prescription keto diet to treat the condition, and could double the number that can use the diet. The makers of the app spoke exclusively to Conan Young.

Jay and Eric talk with Autumn Karen on a challenging subject – A rare chromosome disorder of her daughter Hermione. Sadly, they lost her at the age of 3.5 years, but those years were blessed with loved and empathy. Episode Highlights: 03:01: Autumn narrates about her tragedy. She states that at first, all looked good, but there was a slight clue that something was wrong which the doctors were not able to put a pin.05:18: There are markers for normal or commonly known syndromes or congenital disabilities, but everything was new and unheard of in Hermione’s case. She had plastic surgery at the age of 3 months.06:29: Interestingly, during the same time, Autumn was doing a psychological dissertation on the topic “How families are told about diagnosis.”07:00: Jay empathizes and supports Autumn saying that it might have been confusing and challenging as a nail already hits you in the head.07:28: At the hospital when Autumn was informed of her daughter’s condition. The doctor coldly asks her to google it.07:40: Jay and Eric discuss how some people don’t understand or communicate with you about your pain during tough times. Eric shares a personal experience about how he felt when doctors don’t show any empathy.09:54: Jay points out mental health crisis is not just for the parents or children; doctors also deal with the same situation. There should be an awareness about the same.13:23: Hermione had a 10% chance of survival when she was born. Autumn discusses the privileges that they got from the government and family members.14:54: Eric puts an important question “What are the options available to those people who don’t have such kind of privileges?”16:58: Jay stresses that the issue should be addressed so that, privileged or not, no child should be left out to get proper care and service.17:56: Autumn shares about Hermione’s seizures; at times, they were for 2 hours.19.24: Autumn confesses that before this tragic incident, she had no idea about Sudden Unexpected Death in Epilepsy (SUDEP).22:30: Autumn takes the listeners to an emotional ride when she narrates Hermione’s last moments.25:01: Jay respected the fact that Autumn did not put Hermione under heavy medication but instead tried her best to give her a normal childhood.28:27: Eric talks about his personal experience with epilepsy and how he jokes about it.32:18: Autumn jokes about how her other two kids took things lightly and made seizure faces.35:20: To help parents who have special needs children, Autumn points out that it is essential to talk about it. There is nothing to be afraid of about it.37:24: Funding is also missing for special needs child welfare.48:00: Eric and Jay discuss that “The importance of discussing how it feels to go back to the house post a tragic loss. This discussion is something that has to happen.”49:32: Jay talks about the importance of meditation.53:57: Family with special needs child tends to isolate from the society, it is important to invite them and make them feel welcome.55:15: Jay asks, “Do you think society is becoming more understanding towards special needs children?”58.31: Jay and Eric motivate Autumn and appreciates that she talks about Hermione. They acknowledge that she is making a change.59:55: Jay points out that the entire situation is more about miscommunication; hence it is crucial to talk about it.01:01:06: Autumns stresses that she is not ashamed to talk about Hermione or her disability.3 Key Points:Autumn knows about life with and without a child with a disability, and she shares how life was like Hermione.Autumn explains the difference between controlled and uncontrolled seizures. She also shares about the percentage of survival. Autumn shares the challenges she faced as a single mom of 3 kids and how society, friends, family, or neighbors can help take the pressure off.Resources Mentioned:www.c22c.org | https://www.purpleday.org/C22C Videohttps://autumnkaren.compurpleday.org

Associate Professor Chris Reid was working as a hospital pharmacist when he saw a series of patients in a neurological ward who were not treatable. “I thought well I can only do so much as a pharmacist. I would like to actually do something at a more fundamental level,” says Associate Professor Reid, Principal Research Fellow, member of Faculty and Head of the Neurophysiology of Excitable Networks Laboratory at the Florey Institute of Neuroscience and Mental Health. “I’ve been very fortunate to be part of the genetic revolution which was started by Professor Sam Berkovic and Professor Ingrid Scheffer from the University of Melbourne. I joined Professor Steve Petrou’s lab at a time when that was very new. “Things have moved incredibly quickly over the last 25 years, which is when the first epilepsy gene was discovered, to a point now where gene therapy is becoming a reality.” Associate Professor Reid is currently developing a new treatment for epilepsy. His research project is part of BioCurate, an independently-operated venture catalyst jointly formed by the University of Melbourne and Monash University. “We do need alternative approaches as well – which is really the program that I’ve been driving with BioCurate. What we’ve done is actually identified a channel in the brain that’s in a hotspot that causes seizure generalisation. That’s when seizures cause the big tonic-clonic seizure that we mostly associate with epilepsy,” says Associate Professor Reid. “We have a small molecule program to design drugs to that target with the view of treating a larger population of epilepsy people. So it’s a two-pronged approach, both of which have their risks, but both of which are moving forward particularly well.” Episode recorded: August 6, 2020. Interviewer: Dr Andi Horvath. Producer, audio engineer and editor: Chris Hatzis. Co-production: Silvi Vann-Wall and Dr Andi Horvath. Banner image: Shutterstock.

Associate Professor Chris Reid was working as a hospital pharmacist when he saw a series of patients in a neurological ward who were not treatable. “I thought well I can only do so much as a pharmacist. I would like to actually do something at a more fundamental level,” says Associate Professor Reid, Principal Research Fellow, member of Faculty and Head of the Neurophysiology of Excitable Networks Laboratory at the Florey Institute of Neuroscience and Mental Health. “I've been very fortunate to be part of the genetic revolution which was started by Professor Sam Berkovic and Professor Ingrid Scheffer from the University of Melbourne. I joined Professor Steve Petrou's lab at a time when that was very new. “Things have moved incredibly quickly over the last 25 years, which is when the first epilepsy gene was discovered, to a point now where gene therapy is becoming a reality.” Associate Professor Reid is currently developing a new treatment for epilepsy. His research project is part of BioCurate, an independently-operated venture catalyst jointly formed by the University of Melbourne and Monash University. “We do need alternative approaches as well – which is really the program that I've been driving with BioCurate. What we've done is actually identified a channel in the brain that's in a hotspot that causes seizure generalisation. That's when seizures cause the big tonic-clonic seizure that we mostly associate with epilepsy,” says Associate Professor Reid. “We have a small molecule program to design drugs to that target with the view of treating a larger population of epilepsy people. So it's a two-pronged approach, both of which have their risks, but both of which are moving forward particularly well.” Episode recorded: August 6, 2020. Interviewer: Dr Andi Horvath. Producer, audio engineer and editor: Chris Hatzis. Co-production: Silvi Vann-Wall and Dr Andi Horvath. Banner image: Shutterstock.

In Segment 1, Dr. Trish Perl, Chief of Infectious Diseases at UT Southwestern Medical School joins us to discuss the latest findings and research on reducing Covid-19 spread. This is some of the latest information from the front lines of clinical data. For Segments 2 and 3, Marjorie Quint-Bouzid, Senior Vice President Women & Infants Specialty Health at Parkland Health & Hospital System joins us to talk about important information regarding labor, delivery and post-delivery child care and particularly how Parkland Health & Hospital System has been adapting with new parents. In Segment 4, Anita Bhansali, M.D., Neurosurgeon who practices at North Texas Neurosurgical & Spine Center in Fort Worth joins us to talk about epilepsy - how many are affected, what exactly is epilepsy, and what are some of the latest treatments. This is an area of medicine that is constantly evolving with new technologies and Dr. Bhansali is here to explain. See acast.com/privacy for privacy and opt-out information.

This is the full interview with Anita Bhansali, M.D., Neurosurgeon who practices at North Texas Neurosurgical & Spine Center in Fort Worth joins us to talk about epilepsy - how many are affected, what exactly is epilepsy, and what are some of the latest treatments. This is an area of medicine that is constantly evolving with new technologies and Dr. Bhansali is here to explain. See acast.com/privacy for privacy and opt-out information.

On this episode of Seizing Life, CURE Taking Flight Grantee Dr. Gemma Carvill explains how genetic discoveries in the lab can lead to precision care in the doctor's office. The post From Lab to Clinic: Genetic Research Is Changing Epilepsy Treatment appeared first on CURE Epilepsy.

CURE Taking Flight Grantee Dr. Gemma Carvill explains how genetic research discoveries in the lab can lead to precision care in the doctor’s office. The post From Lab to Clinic: Genetic Research Is Changing Epilepsy Treatment appeared first on CURE Epilepsy.

CURE Taking Flight Grantee Dr. Gemma Carvill explains how genetic research discoveries in the lab can lead to precision care in the doctor’s office. The post From Lab to Clinic: Genetic Research Is Changing Epilepsy Treatment appeared first on CURE Epilepsy.

मिर्गी का इलाज || Epilepsy Treatment In Hindi Ke podcast se janenge ap mirgi ka ilaj kaise hota hai, dawao dwara kaise hota hia ilaj, achchhe ilaj ke liye kin bato ka rakkhe khayal, mirgi me kon kon si surgery dwara ilaj hota hai, mirgi ke karan lakshan kya hote hai aur bhi bhut kuch janenge ap humare is mirgi ke podcast se मिर्गी के कारण, लक्षण व डायग्नोसिस ||Epilepsy Causes, Symptoms & Diagnosis part-1 https://youtu.be/pqdP2gjhtWU मिर्गी से कैसे निपटें ? || How To Manage Epilepsy In An Emergency Situation || in Hindi part-3 https://youtu.be/vo1D6EVu06g मिर्गी में क्या खाना चाहिए क्या नही खाना चाहिए? || Epilepsy Me Kya Khaye Kya Na Khaye? part-4 https://youtu.be/d9cFcE3ZgGs Subscribe the channel. It's free- https://www.youtube.com/channe/UC5IcI... Facebook- https://www.facebook.com/XzimerOn/ Twitter- https://twitter.com/xzimer?s=09 --- Send in a voice message: https://anchor.fm/xzimer-medicare/message

Penobarbital is one of the most common drugs used in the treatment of dog epilepsy and to control seizures. Before starting, you need to know how well it works, learn about the side-effects and how to monitor your epileptic dog taking phenobarbital. Epilepsy and seizures is a distressing condition for your dog to be diagnosed with but with the right treatment the seizures can be very well controlled. Phenobarbital is often the first choice and this episode goes through what you need to know about this epilepsy treatment for dogs. Show notes: https://ourpetshealth.com/info/phenobarbital-dog-epilepsy-treatment

This week, medical uses of cannabis. What's the hype and what's the reality? We hear from the people who grow it, and the people who want to use it. Plus in the news, scientists grow replacement lungs in a lab, why a knock on the head can lead to dementia years later, and the very tiny thing that elephants are terrified of - and no, it's not a mouse! Like this podcast? Please help us by supporting the Naked Scientists

This week, medical uses of cannabis. What's the hype and what's the reality? We hear from the people who grow it, and the people who want to use it. Plus in the news, scientists grow replacement lungs in a lab, why a knock on the head can lead to dementia years later, and the very tiny thing that elephants are terrified of - and no, it's not a mouse! Like this podcast? Please help us by supporting the Naked Scientists

In this episode of Hallway Conversations, Epilepsy.com Editor-In-Chief Dr. Joseph Sirven interviews  Dr. Nicolas Gaspard, Critical Care Neurologist  in Brussels, Belgium regarding the new New Onset Refractory Status Epilepticus (NORSE).  What is it and how is this seizure emergency managed?

Advocates and researchers are hopeful that the bill will be signed into law, despite the previous remarks of Gov. Holcomb

Host: Jennifer Caudle, DO Guest: Kathryn Davis, MD, MTR Guest: Timothy Lucas, MD, PhD According to the epilepsy foundation, epilepsy is the 4th most common neurological problem in the U.S. – only migraine, stroke and Alzheimer's disease occur more frequently. The average incidence of epilepsy each year in the U. S is estimated at 150,000, or 48 for every 100,000 people. Host Dr. Jennifer Caudle talks with Doctors Kathryn Davis and Timothy Lucas about advances in treatment for epilepsy at Penn Medicine. Dr. Davis is Assistant Professor of Neurology and Medical Director of the Epilepsy Monitoring Unit and Epilepsy Surgical Program. Dr. Timothy Lucas is Assistant Professor of Neurosurgery, Surgical Director at the Penn Epilepsy Center, and Director of the Penn Center for Laser Neurosurgery.

Host: Jennifer Caudle, DO Guest: Kathryn Davis, MD, MTR Guest: Timothy Lucas, MD, PhD According to the epilepsy foundation, epilepsy is the 4th most common neurological problem in the U.S. – only migraine, stroke and Alzheimer’s disease occur more frequently. The average incidence of epilepsy each year in the U. S is estimated at 150,000, or 48 for every 100,000 people. Host Dr. Jennifer Caudle talks with Doctors Kathryn Davis and Timothy Lucas about advances in treatment for epilepsy at Penn Medicine. Dr. Davis is Assistant Professor of Neurology and Medical Director of the Epilepsy Monitoring Unit and Epilepsy Surgical Program. Dr. Timothy Lucas is Assistant Professor of Neurosurgery, Surgical Director at the Penn Epilepsy Center, and Director of the Penn Center for Laser Neurosurgery.

Host: Jennifer Caudle, DO Guest: Kathryn Davis, MD, MTR Guest: Timothy Lucas, MD, PhD According to the epilepsy foundation, epilepsy is the 4th most common neurological problem in the U.S. – only migraine, stroke and Alzheimer’s disease occur more frequently. The average incidence of epilepsy each year in the U. S is estimated at 150,000, or 48 for every 100,000 people. Host Dr. Jennifer Caudle talks with Doctors Kathryn Davis and Timothy Lucas about advances in treatment for epilepsy at Penn Medicine. Dr. Davis is Assistant Professor of Neurology and Medical Director of the Epilepsy Monitoring Unit and Epilepsy Surgical Program. Dr. Timothy Lucas is Assistant Professor of Neurosurgery, Surgical Director at the Penn Epilepsy Center, and Director of the Penn Center for Laser Neurosurgery.

Host: Jennifer Caudle, DO Guest: Kathryn Davis, MD, MTR Guest: Timothy Lucas, MD, PhD According to the epilepsy foundation, epilepsy is the 4th most common neurological problem in the U.S. – only migraine, stroke and Alzheimer’s disease occur more frequently. The average incidence of epilepsy each year in the U. S is estimated at 150,000, or 48 for every 100,000 people. Host Dr. Jennifer Caudle talks with Doctors Kathryn Davis and Timothy Lucas about advances in treatment for epilepsy at Penn Medicine. Dr. Davis is Assistant Professor of Neurology and Medical Director of the Epilepsy Monitoring Unit and Epilepsy Surgical Program. Dr. Timothy Lucas is Assistant Professor of Neurosurgery, Surgical Director at the Penn Epilepsy Center, and Director of the Penn Center for Laser Neurosurgery.

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Orrin Devinsky, MD about medical marijuana for epilepsy.

In this week's episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews José E. Cavazos, M.D., Ph.D., F.A.A.N., Associate Professor of Neurology, Pharmacology and Physiology, University of Texas Health Science Center at San Antonio, about Neurocysticercosis and Epilepsy. This is a live taping with no questions to be answered live.

In this week's episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Joseph Drazkowski, MD Associate Professor of Neurology, Mayo Clinic and Matthew Hoerth, MD Instructor in Neurology, Mayo Clinic about Epilepsy caused by Antibodies or Autoimmune Epilepsy. This is a live taping with no questions to be answered live.

In this week's episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Ilo Leppik, MD, Director of Research at MINCEP Epilepsy Care, Professor of Pharmacology and Neurology at the University of Minnesota about Epilepsy in Older Adults: Latest research and treatment. This is a live taping with no questions to be answered live.

In this week's episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, discusses highlights of epilepsy research recently presented at the American Academy of Neurology meeting in, Toronto, Ontario, Canada from April 11- 16. It is a live taping with no questions to be answered live.

In this week's episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Dr. Lawrence J. Hirsch, Associate Clinical Professor of Neurology, Comprehensive Epilepsy Center, Columbia University on the latest management of Status Epilepticus. This is a live taping with no questions to be answered live.

Dr. Joe Sirven, Editor-in-Chief of epilepsy.com/professionals interviews Epilepsy Therapy Project (ETP) Chairman Warren Lammert and President Joyce Cramer about new therapies for epilepsy and "Pipeline Day" at the AED Trials X Conference. Pipeline Day focuses on new therapies being researched and worked on. ETP's mission is to advance new treatments for people living with epilepsy by fast-tracking great ideas into treatments to reach people as fast as possible.